These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4260342)

  • 21. Functional role of the nigro-neostriatal dopamine neurons.
    Andén NE; Dahlström A; Fuxe K; Larsson K
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):263-74. PubMed ID: 5297995
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors.
    Vítek V; Rysánek K
    Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine mediation of the morphine-induced activation of mice.
    Carroll BJ; Sharp PT
    Br J Pharmacol; 1972 Sep; 46(1):124-39. PubMed ID: 4263794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine, noradrenaline and 5-hydroxy-trytamine in relation to motor activity, fighting and mounting behaviour. II. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602 and parachlorophenylalanine.
    Benkert O; Renz A; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):187-93. PubMed ID: 4266876
    [No Abstract]   [Full Text] [Related]  

  • 25. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
    Bartholini G; Constantinidis J; Tissot R; Pletscher A
    Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
    [No Abstract]   [Full Text] [Related]  

  • 26. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative studies on monoamine oxidase inhibitors].
    Matthies H; Lietz W; Fähse C; Pohle W; Popov N; Grade K
    Acta Biol Med Ger; 1966; 17(5):614-36. PubMed ID: 5991587
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperactive states related to the metabolism of norepinephrine and similar biochemicals.
    Scheckel CL; Boff E; Pazery LM
    Ann N Y Acad Sci; 1969 Jul; 159(3):939-58. PubMed ID: 4981886
    [No Abstract]   [Full Text] [Related]  

  • 29. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoamine precursors and copulatory behavior in the male rat.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():47-68. PubMed ID: 4546480
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
    [No Abstract]   [Full Text] [Related]  

  • 34. Formation and storage of 5-hydroxytryptamine in thyroid parafollicular cells.
    Ericson LE
    J Ultrastruct Res; 1972 Dec; 41(5):467-83. PubMed ID: 4539252
    [No Abstract]   [Full Text] [Related]  

  • 35. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 36. Bizarre social behaviour in rats induced by a combination of a peripheral decarboxylase inhibitor and DOPA.
    Lammers AJ; van Rossum JM
    Eur J Pharmacol; 1968 Dec; 5(1):103-6. PubMed ID: 5718509
    [No Abstract]   [Full Text] [Related]  

  • 37. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
    Reis DJ; Moorhead DT; Merlino N
    Arch Neurol; 1970 Jan; 22(1):31-9. PubMed ID: 4391435
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of monoamines in ovulation: evidence for a serotoninergic pathway for inhibition of spontaneous ovulation.
    Labhsetwar AP
    J Endocrinol; 1972 Aug; 54(2):269-75. PubMed ID: 4262744
    [No Abstract]   [Full Text] [Related]  

  • 40. A serotonergic system involved in the grooming behavior of cats with pontile lesion.
    Randall W; Trulson M
    Pharmacol Biochem Behav; 1974 May; 2(3):355-60. PubMed ID: 4276152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.